# What 519 GLP-1 Signup Funnels Look Like

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-19 | Updated: 2026-10-27

Canonical page: https://glpwatchdog.org/research/what-519-signup-funnels-look-like

> Thirty percent of GLP-1 sellers show no price until you have completed a medical intake. A majority publish no list of the states they serve. What the signup pages of 519 sellers reveal.

## Key points

- 519 funnels walked in systematic passes across July–August 2026, each with a recorded date.
- 157 of them (30%) show no price until the intake is complete.
- 324 of 556 sellers publish no list of the states they serve.
- Video-visit figures are a ratio among the 94 cases where it was determinable, not a market rate.

Reading a seller’s website tells you what it claims. Walking its signup funnel tells you what it does. We have walked **519** of them, in systematic passes between July and August 2026, and dated every one. The most consistent difference between sellers is not price or product but whether they tell you the price before or after you hand over your health information.

## Where the price appears

Of 519 funnels walked, **362** showed a price before the intake began. **157**, almost exactly 30%, showed nothing until the questionnaire was complete.

That split is the most useful single fact we hold about this market. It divides sellers into ones you can comparison-shop and ones you cannot, and it does so before any question of quality arises. A price you can only obtain by submitting medical details is not a price you can compare; it is a price you are shown once you are already invested.

Seeing a price first is not the same as being reviewed first. [MEDVi](https://glpwatchdog.org/reviews/medvi) and [ElixaMD](https://glpwatchdog.org/reviews/elixamd) both show their prices before any medical questions, then take payment before a clinician looks at the case. [Trinity Meds](https://glpwatchdog.org/reviews/trinity-meds) also charges at checkout, and its refund policy says that paying without finishing the intake earns no refund.

> Seventy percent will tell you. The remaining thirty percent want your health history first.

> **The gate is doing something deliberate.** Completing an intake takes several minutes and creates a small sense of commitment, and that sunk cost is the point. It also hands the seller a lead it can follow up regardless of whether you buy. Neither is sinister on its own, and both are reasons the number shown afterward should be treated with more suspicion than one published openly.

A few sellers move the payment step to the very end. At [Fifty 410](https://glpwatchdog.org/reviews/fifty-410), the intake and the provider appointment happen without a card, and you pay through a link that is sent only after a prescription is issued.

## What a walk involves

We stop before any account is created, before payment, and before personal health data is submitted. That is why some funnels can only be characterized so far. The walk records four things: when the price appears, whether a live clinician visit is required, whether bloodwork is asked for, and how support can be reached.

Contact details were recorded for 343 sellers, and the most common form by far is an email address. A market that sells a prescription medication mostly supports it by email.

## What we know about video visits

Here we have to be careful about what we know. The requires-a-video-visit question was answerable in only 94 of the 519 walks. Among those 94, **63 required one** and 31 did not.

It would be easy and wrong to turn that into “63 of 556 sellers require a video visit”, because that phrasing implies we established the other 493 do not. We did not. What can be said is narrower: where the funnel made it clear, roughly two thirds required a live visit. That is a more encouraging picture than the market’s reputation suggests, though it is drawn from a sample we cannot prove is representative.

> A live clinician visit is slower than a form and it is the more careful intake. It is also the thing most easily removed to increase conversion. If you are choosing between two sellers, the one that insists on talking to you is telling you where its priorities sit. See [what makes a telehealth prescription legitimate](https://glpwatchdog.org/research/what-makes-a-telehealth-glp1-prescription-legitimate).

## The state-list problem

Separately from the funnel walks, **324 of 556 sellers**, a clear majority, publish no list of the states they serve.

This matters more than it sounds. A telehealth prescription must come from a clinician licensed in *your* state, so which states a seller operates in is not a marketing detail. It determines whether the seller can legally treat you at all. Among the sellers that do publish a list, coverage skews the way populations do: [Texas](https://glpwatchdog.org/states/texas), Florida and Arizona appear most often, while Mississippi, Arkansas, Alaska and Hawaii appear least. The District of Columbia is served by a small fraction of them.

If you live somewhere less commonly served, the practical consequence is that the published lists are worth more to you than to anyone else, and a seller that will not publish one is asking you to find out during intake.

## How to use this before you sign up

1. **Find the price before starting an intake.** If you cannot, note that you are in the 30% and let it weigh on the decision.
2. **Check whether your state is listed** before answering any medical question. A majority of sellers will not tell you, which is itself informative.
3. **Notice whether a live visit is required.** Slower is usually more careful here.
4. **Look at how support is reached.** An email address is the norm; a phone number is a meaningful upgrade when something goes wrong.
5. **Stop at the first medical question if the basics are still missing.** Price, states and pharmacy should all be answerable before you disclose anything.

Our [comparison tool](https://glpwatchdog.org/compare) filters on what each seller publishes, which is the fastest way to skip the gated 30% entirely.

## Frequently asked questions

### How many GLP-1 sellers hide their price behind an intake?

Of 519 signup funnels we walked, 157, almost exactly 30%, showed no price until the questionnaire was complete. The other 362 published one before the intake began.

### Why does it matter when the price appears?

Because a price you can only obtain by submitting medical details is not one you can comparison-shop. Completing an intake also takes time and creates a sense of commitment, and it hands the seller a lead regardless of whether you buy.

### Do most sellers require a video visit with a clinician?

We can only answer for the funnels where it was determinable: 94 of 519. Among those, 63 required a live visit and 31 did not. That is roughly two thirds of a sample we cannot prove is representative, so it should not be read as a rate across the whole market.

### How do I know if a seller operates in my state?

Often you cannot from the website: 324 of 556 sellers publish no state list. This matters because a telehealth prescription must come from a clinician licensed in your state, so it determines whether a seller can legally treat you at all.

### How do you walk a funnel without signing up?

We stop before creating an account, before payment, and before submitting personal health data. That limits what can be established for some sellers, and it is why certain fields are recorded for only part of the register rather than all of it.

## References

1. GLP Watchdog. Provider register — signup funnel walks recorded per seller with individual walk dates; 519 of 556 listed sellers, computed August 19, 2026. GLP Watchdog register. 2026. https://glpwatchdog.org/compare

---

Cite as: GLP Watchdog, Ruth Calder, "What 519 GLP-1 Signup Funnels Look Like", published 2026-08-19, updated 2026-10-27. https://glpwatchdog.org/research/what-519-signup-funnels-look-like

Canonical HTML page: https://glpwatchdog.org/research/what-519-signup-funnels-look-like

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
